Supplier

EXACT SCIENCES UK LTD

Value won

£1.1m

Across 3 contracts won

A United Kingdom supplier, with 3 awarded contracts, totalling £1.1m, most recently 7 days ago.

United Kingdom(inferred)

Track EXACT SCIENCES UK LTD

We'll email you when they win a contract · Free · No card

Value won

£1.1m

Across 3 contracts won

Contract history

3 entries

Most recent
26 Oct 2026
7 days ago
Biggest
£405k
Oncotype DX Breast Recurrence Score…
Average size
£375.2k
Across 3 priced
Last 12 months
3
entries

Won · 3

Oncotype DX Breast Recurrence Score Test£405,000 · 26 Oct 2026 Oncotype DX Breast Recurrence Score Test£405,000 · 26 Oct 2026 Oncotype DX Breast Cancer Tests Contract£315,600 · 27 Feb 2026

Feb 26Apr 26Jun 26Sept 26Nov 26

Opportunities

Showing awarded · 3

AwardedHealthcare & MedicalUnited Kingdom

Oncotype DX Breast Recurrence Score Test

Procurement opportunity for Oncotype DX breast cancer recurrence scoring assay with established clinical validation and single current global supplier.

£405,000LEEDS TEACHING HOSPITALS NHS TRUST

Published 26 Oct 2026

AwardedHealthcare & MedicalUnited Kingdom

Oncotype DX Breast Recurrence Score Test

Clinically validated genetic test for predicting chemotherapy benefit and guiding personalized breast cancer treatment decisions.

£405,000LEEDS TEACHING HOSPITALS NHS TRUST

Published 26 Oct 2026

AwardedHealthcare & MedicalUnited Kingdom

Oncotype DX Breast Cancer Tests Contract

This contract is for the provision of Oncotype DX Breast Recurrence Score tests, which are essential for assessing the risk of breast cancer recurrence in patients. The contract is a call-off from an existing framework agreement, allowing the Norfolk and Norwich University Hospitals NHS Foundation T

est.£315,600NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

Published 27 Feb 2026